The Programmed Death-1 Ligand 1:B7-1 Pathway Restrains Diabetogenic Effector T Cells In VivoAlison M. Paterson, Arlene H. Sharpe, Anil Chandraker et al.|The Journal of Immunology|2011Cited by 205